Related Experiment Video
Updated: Jan 16, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Differences in respiratory wheezing between current exclusive e-cigarette users, current exclusive cigarette smokers,
Yusuff Adebayo Adebisi1,2, Najim Z Alshahrani3, Lucia Spicuzza4,5,6
1College of Social Sciences, University of Glasgow, 40 Bute Gardens, Glasgow, G12 8RT, UK. y.adebisi.1@research.gla.ac.uk.
Background:
E-cigarettes have emerged as an alternative to combustible cigarettes, yet their comparative impact on respiratory symptoms remains uncertain. We investigated cross-sectional differences in self-reported wheezing between current exclusive e-cigarette users, current exclusive cigarette smokers, and never-users of either product.
Methods:
We analysed data from 9000 adults aged ≥ 16 years in the 2017-2019 Scottish Health Survey. The exposure was current nicotine use status (exclusive cigarette smoking, exclusive e-cigarette use, or never-use), and the outcome was self-reported wheezing in the past 12 months. Binary multivariable logistic regression estimated adjusted odds ratios (ORs) with 95% confidence intervals (CIs), controlling for age, sex, area-level socioeconomic deprivation, longstanding illness, doctor-diagnosed asthma and COPD, self-rated general health, alcohol consumption, age of smoking initiation, and exposure to second-hand smoke.
Results:
Compared to exclusive e-cigarette users, exclusive cigarette smokers had significantly higher odds of wheezing (adjusted OR = 1.80, 95% CI: 1.33-2.42, p < 0.001). Never-users had lower odds of wheezing than exclusive e-cigarette users, though the difference was not significant (adjusted OR = 0.66, 95% CI: 0.31-1.40, p = 0.275). Among exclusive cigarette smokers, the odds of wheezing increased with smoking intensity relative to exclusive e-cigarette users, indicating a dose-response relationship (χ² = 5.91, p = 0.018). Specifically, light smokers (< 10 cigarettes/day) had elevated but not significant odds (adjusted OR = 1.32, 95% CI: 0.92-1.89, p = 0.133), while moderate smokers (10-19 cigarettes/day) showed higher odds (adjusted OR = 1.85, 95% CI: 1.33-2.59, p < 0.001), and heavy smokers (≥ 20 cigarettes/day) had the greatest odds (adjusted OR = 2.27, 95% CI: 1.57-3.28, p < 0.001). Adjusted predicted probabilities of wheezing mirrored this pattern: compared with exclusive e-cigarette users, probabilities were significantly higher for moderate smokers (+ 7.2%, p = 0.002) and heavy smokers (+ 10.0%, p < 0.001), but not for light smokers (+ 3.0%, p = 0.152) or never-users (-3.9%, p = 0.306).
Conclusions:
Exclusive e-cigarette use was not associated with higher odds of wheezing compared with never-use, and it was linked to substantially lower odds than exclusive cigarette smoking. These findings suggest that, while complete abstinence remains the lowest-risk option, e-cigarette use may pose fewer respiratory symptoms than smoking, particularly for moderate-to-heavy smokers.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Statistical Methods for Analyzing Epidemiological Data
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-I: Introduction